Jefferies Maintains a “Buy” Rating on West Pharm (WST) and $115.0 Target; Ngam Advisors LP Decreased Its Baxter Intl (BAX) Holding

Ngam Advisors Lp decreased Baxter Intl Inc (BAX) stake by 7.86% reported in 2017Q3 SEC filing. Ngam Advisors Lp sold 12,949 shares as Baxter Intl Inc (BAX)’s stock rose 15.04%. The Ngam Advisors Lp holds 151,822 shares with $9.53M value, down from 164,771 last quarter. Baxter Intl Inc now has $36.20 billion valuation. The stock increased 0.62% or $0.41 during the last trading session, reaching $66.44. About 2.06M shares traded. Baxter International Inc. (NYSE:BAX) has risen 32.55% since February 16, 2017 and is uptrending. It has outperformed by 15.85% the S&P500.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. West Pharmaceutical Services has $115 highest and $69 lowest target. $100.50’s average target is 13.76% above currents $88.34 stock price. West Pharmaceutical Services had 14 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, September 15 by Jefferies. The stock has “Hold” rating by Jefferies on Tuesday, June 6. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) earned “Market Perform” rating by Wells Fargo on Wednesday, September 21. The firm earned “Outperform” rating on Tuesday, March 22 by Wells Fargo. The firm has “Hold” rating by Zacks given on Tuesday, August 4. The rating was upgraded by Wells Fargo to “Outperform” on Friday, October 28. Wells Fargo maintained West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, October 27. Wells Fargo has “Outperform” rating and $112 target. The rating was maintained by Jefferies with “Hold” on Thursday, July 27. Jefferies maintained West Pharmaceutical Services, Inc. (NYSE:WST) on Monday, September 11 with “Hold” rating. The rating was maintained by Jefferies with “Hold” on Thursday, June 29.

Since August 17, 2017, it had 0 buys, and 3 insider sales for $1.39 million activity. 12,670 shares were sold by Accogli Giuseppe, worth $772,363. Another trade for 4,020 shares valued at $247,672 was sold by Shapazian Carole J. 9,440 shares valued at $583,014 were sold by FORSYTH JOHN D on Friday, August 25. STALLKAMP THOMAS T sold 8,920 shares worth $555,538.

Ngam Advisors Lp increased Illinois Tool Wks Inc (NYSE:ITW) stake by 4,836 shares to 141,207 valued at $20.89M in 2017Q3. It also upped Grifols S A (NASDAQ:GRFS) stake by 21,690 shares and now owns 653,762 shares. Marvell Technology Group Ltd (NASDAQ:MRVL) was raised too.

Investors sentiment increased to 0.97 in 2017 Q3. Its up 0.05, from 0.92 in 2017Q2. It improved, as 38 investors sold BAX shares while 300 reduced holdings. 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 were reported. Clinton Group has 95,141 shares for 0.66% of their portfolio. Assetmark invested in 6,535 shares or 0% of the stock. Livforsakringsbolaget Skandia Omsesidigt owns 33,015 shares. Trustmark State Bank Trust Department holds 0.07% or 9,065 shares in its portfolio. 7,439 are held by Koch Industrial Inc. Winslow Evans & Crocker holds 0.05% of its portfolio in Baxter International Inc. (NYSE:BAX) for 2,190 shares. Vanguard Group reported 0.1% in Baxter International Inc. (NYSE:BAX). 188,842 were accumulated by Nordea Investment Mgmt. Stillwater Invest Mgmt Ltd Com reported 20,205 shares stake. Moors And Cabot reported 59,656 shares. Ameriprise Fincl invested in 8.20M shares. Moreover, Gamco Et Al has 0.05% invested in Baxter International Inc. (NYSE:BAX). Illinois-based Northern Tru has invested 0.15% in Baxter International Inc. (NYSE:BAX). 197,888 are held by British Columbia Management. Fmr Ltd has invested 0.06% in Baxter International Inc. (NYSE:BAX).

Among 19 analysts covering Baxter International (NYSE:BAX), 11 have Buy rating, 0 Sell and 8 Hold. Therefore 58% are positive. Baxter International had 55 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Baxter International Inc. (NYSE:BAX) has “Hold” rating given on Friday, April 28 by BMO Capital Markets. BMO Capital Markets maintained the stock with “Buy” rating in Monday, November 13 report. The rating was downgraded by S&P Research to “Hold” on Friday, July 31. RBC Capital Markets maintained the stock with “Sector Perform” rating in Thursday, April 27 report. The company was maintained on Friday, February 2 by Barclays Capital. As per Thursday, October 13, the company rating was initiated by Wells Fargo. The firm has “Neutral” rating by Credit Suisse given on Monday, April 25. RBC Capital Markets maintained Baxter International Inc. (NYSE:BAX) rating on Monday, October 2. RBC Capital Markets has “Hold” rating and $60.0 target. The stock of Baxter International Inc. (NYSE:BAX) has “Hold” rating given on Monday, July 10 by RBC Capital Markets. The rating was maintained by Stifel Nicolaus on Monday, February 5 with “Hold”.

Since December 8, 2017, it had 0 insider buys, and 1 insider sale for $2.08 million activity. Another trade for 21,000 shares valued at $2.08 million was sold by FEDERICI WILLIAM J.

The stock decreased 7.05% or $6.7 during the last trading session, reaching $88.34. About 1.04M shares traded or 211.41% up from the average. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 33.75% since February 16, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company has market cap of $6.56 billion. The company's Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It has a 35.35 P/E ratio. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.28, from 1.61 in 2017Q2. It dived, as 31 investors sold West Pharmaceutical Services, Inc. shares while 76 reduced holdings. 42 funds opened positions while 100 raised stakes. 68.09 million shares or 1.49% more from 67.09 million shares in 2017Q2 were reported. Thrivent Fincl For Lutherans owns 137,218 shares. Commonwealth Equity Serv holds 0% or 2,711 shares in its portfolio. The Texas-based Texas Permanent School Fund has invested 0.07% in West Pharmaceutical Services, Inc. (NYSE:WST). Panagora Asset Mngmt accumulated 1,307 shares. Parametric Portfolio Associates Ltd Liability invested in 81,077 shares. Invesco, a Georgia-based fund reported 348,690 shares. Regions reported 4,095 shares. Bamco New York accumulated 1.81 million shares. Dimensional Fund Ltd Partnership has 336,027 shares. Oregon Employees Retirement Fund owns 27,116 shares. Fdx Advsrs reported 7,104 shares. Tcw Gru Inc has 0.24% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 315,268 shares. First Quadrant L P Ca, California-based fund reported 279,895 shares. Qs Ltd Liability invested in 2,706 shares. 229,059 are owned by Public Employees Retirement Association Of Colorado.